{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T18:21:49Z","timestamp":1715797309019},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s11655-0112-0962-9","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T06:49:26Z","timestamp":1326091766000},"page":"16-22","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of ursodeoxycholic acid combined with Tongdan Decoction (\u901a\u80c6\u6c64) on immunological indices and histopathological changes in primary biliary cirrhosis patients"],"prefix":"10.1007","volume":"18","author":[{"given":"Guang-dong","family":"Tong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-hong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-shan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-song","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-zhou","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-jun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-qiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,10]]},"reference":[{"key":"962_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1665-2681(19)32061-7","volume":"4","author":"P. Charatcharoenwitthaya","year":"2005","unstructured":"Charatcharoenwitthaya P, Lindor KD. Current concepts in the pathogenesis of primary biliary cirrhosis. Ann Hepatol 2005;4:161\u2013175.","journal-title":"Ann Hepatol"},{"key":"962_CR2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1089-3261(03)00101-6","volume":"7","author":"U. Leuschner","year":"2003","unstructured":"Leuschner U. Primary biliary cirrhosis\u2014presentation and diagnosis. Clin Liver Dis 2003;7:741\u2013758.","journal-title":"Clin Liver Dis"},{"key":"962_CR3","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.gastro.2003.08.022","volume":"125","author":"Y. Dahlan","year":"2003","unstructured":"Dahlan Y, Smith L, Simmonds D, Jewell LD, Wanless I, Heathcote EJ, Bain VG. Pediatric-onset primary biliary cirrhosis. Gastroenterology 2003;125:1476\u20131479.","journal-title":"Gastroenterology"},{"key":"962_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-3-1","volume":"3","author":"T. Kumagi","year":"2008","unstructured":"Kumagi T, Heathcote EJ. Primary biliary cirrhosis. Orphanet J Rare Dis 2008;3:1.","journal-title":"Orphanet J Rare Dis"},{"key":"962_CR5","first-page":"163","volume":"41","author":"F. Zhang","year":"2002","unstructured":"Zhang F, Jia J, Wang B, Qian L, Yin S, Wang Y, et al. Clinical characteristics of primary biliary cirrhosis: a report of 45 cases. Chin J Int Med (Chin) 2002;41:163\u2013167.","journal-title":"Chin J Int Med (Chin)"},{"key":"962_CR6","first-page":"146","volume":"7","author":"G.B. Yao","year":"2002","unstructured":"Yao GB. A prospective study of primary biliary cirrhosis in Chinese patients. Chin Hepatol (Chin) 2002;7:146\u2013149.","journal-title":"Chin Hepatol (Chin)"},{"key":"962_CR7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00004836-200308000-00018","volume":"37","author":"J.L. Siegel","year":"2003","unstructured":"Siegel JL, Jorgensen R, Angulo P, Lindor KD. Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis. J Clin Gastroenterol 2003;37:183\u2013185.","journal-title":"J Clin Gastroenterol"},{"key":"962_CR8","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMct074694","volume":"357","author":"K. Lindor","year":"2007","unstructured":"Lindor K. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. N Engl J Med 2007;357:1524\u20131529.","journal-title":"N Engl J Med"},{"key":"962_CR9","first-page":"165","volume":"46","author":"A. Pares","year":"2000","unstructured":"Pares A, Rodes J. Treatment of primary biliary cirrhosis. Minerva Gastroenterol Dietol 2000;46:165\u2013174.","journal-title":"Minerva Gastroenterol Dietol"},{"key":"962_CR10","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","volume":"324","author":"R.E. Poupon","year":"1991","unstructured":"Poupon RE, Balkau B, Eschwege E, Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med 1991;324:1548\u20131554.","journal-title":"N Engl J Med"},{"key":"962_CR11","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","volume":"19","author":"E.J. Heathcote","year":"1994","unstructured":"Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, et al. The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994;19:1149\u20131156.","journal-title":"Hepatology"},{"key":"962_CR12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","volume":"354","author":"J. Goulis","year":"1999","unstructured":"Goulis J, Leandro G, Burroughs AK. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet 1999;354:1053\u20131060.","journal-title":"Lancet"},{"key":"962_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(03)00192-2","volume":"39","author":"R.E. Poupon","year":"2003","unstructured":"Poupon RE, Lindor KD, Pares A, Chazouilleres O, Poupon R, Heathcote EJ. Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. J Hepatol 2003;39:12\u201316.","journal-title":"J Hepatol"},{"key":"962_CR14","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/j.1572-0241.2006.00699.x","volume":"101","author":"P.C. Borg ter","year":"2006","unstructured":"ter Borg PC, Schalm SW, Hansen BE, van Buuren HR. Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10yr cohort study involving 297 patients. Am J Gastroenterol 2006;101:2044\u20132050.","journal-title":"Am J Gastroenterol"},{"key":"962_CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","volume":"379","author":"J. Ludwig","year":"1978","unstructured":"Ludwig J, Dickson ER, Mcdonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 1978;379:103\u2013112.","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"962_CR16","volume-title":"Bases and clinics of autoimmune liver diseases","author":"D.K. Qiu","year":"2006","unstructured":"Qiu DK, Ma X. Bases and clinics of autoimmune liver diseases. Shanghai: Shanghai Scientific and Technical Publishers (Chin); 2006."},{"key":"962_CR17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/cmi.2010.40","volume":"7","author":"D. Wang","year":"2010","unstructured":"Wang D, Zhang H, Liang J, Gu Z, Zhou Q, Fan X, et al. CD4+ CD25+ but not CD4+ Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis. Cell Mol Immunol 2010;7:485\u2013490.","journal-title":"Cell Mol Immunol"},{"key":"962_CR18","first-page":"740","volume":"18","author":"Y. Zhang","year":"2010","unstructured":"Zhang Y, Chen WZ, Shi JM. Effect of estrogen receptor alpha gene polymorphism on the variations of T lymphocyte subsets and its related cell factors in female patients with primary cholestasis cirrhosis. Chin J Hepatol (Chin) 2010;18:740\u2013744.","journal-title":"Chin J Hepatol (Chin)"},{"key":"962_CR19","first-page":"140","volume":"3","author":"C.Z. Su","year":"2011","unstructured":"Su CZ, Dong HH, Zhong R. Treatment of primary biliary cirrhosis with Chinese medicine. J China Tradit Chin Med Inform (Chin) 2011;3:140.","journal-title":"J China Tradit Chin Med Inform (Chin)"},{"key":"962_CR20","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.11569\/wcjd.v16.i13.1417","volume":"16","author":"H. Tang","year":"2008","unstructured":"Tang H, Chen Y, Tong G, Zhou D, He J, Zhou X, Zheng Y. Efficacy of ursodeoxycholic acid combined with Tongdan Decoction in treatment of patients with primary biliary cirrhosis. World Chin J Digestol (Chin) 2008;16:1417\u20131424.","journal-title":"World Chin J Digestol (Chin)"},{"key":"962_CR21","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","volume":"31","author":"E.J. Heathcote","year":"2000","unstructured":"Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 2000;31:1005\u20131013.","journal-title":"Hepatology"},{"key":"962_CR22","first-page":"324","volume":"8","author":"Chinese Medical Association.","year":"2000","unstructured":"Chinese Medical Association. Prevention and solution of viral hepatitis. Chin J Hepatol (Chin) 2000;8:324.","journal-title":"Chin J Hepatol (Chin)"},{"key":"962_CR23","first-page":"1625","volume":"82","author":"G. Chen","year":"2002","unstructured":"Chen G, Li L, Gao J, Li F, Li B. Primary biliary cirrhosis: an analysis of 153 cases. Chin Med J (Chin) 2002;82:1625\u20131628.","journal-title":"Chin Med J (Chin)"},{"key":"962_CR24","first-page":"396","volume":"15","author":"P. Zhao","year":"2007","unstructured":"Zhao P, Zhu L, Yao DK. Progress in the study of recurrent primary biliary cirrhosis after orthotopic liver transplantation. Chin J Hepatol (Chin) 2007;15:396\u2013398.","journal-title":"Chin J Hepatol (Chin)"},{"key":"962_CR25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0676.1997.tb00793.x","volume":"17","author":"R. Klein","year":"1997","unstructured":"Klein R, Pointner H, Zilly W, Glassner-Bittner B, Breuer N, Garbe W, et al. Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years. Liver 1997;17:119\u2013128.","journal-title":"Liver"},{"key":"962_CR26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-8278(05)80056-X","volume":"20","author":"R. Klein","year":"1994","unstructured":"Klein R, Huizenga JR, Gips CH, Berg PA. Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation. J Hepatol 1994;20:181\u2013189.","journal-title":"J Hepatol"},{"key":"962_CR27","first-page":"209","volume":"14","author":"W.J. Duan","year":"2009","unstructured":"Duan WJ, Jia JD, Diagnosis and Management of Primary Biliary Cirrhosis. Chin J Gastroenterol (Chin) 2009;14:209\u2013213.","journal-title":"Chin J Gastroenterol (Chin)"},{"key":"962_CR28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaut.2010.06.004","volume":"35","author":"F. Bernuzzi","year":"2010","unstructured":"Bernuzzi F, Fenoglio D, Battaglia F, Fravega M, Gershwin ME, Indiveri F, et al. Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis. J Autoimmun 2010;35:176\u2013180.","journal-title":"J Autoimmun"},{"key":"962_CR29","first-page":"620","volume":"16","author":"Y.F. Jiang","year":"2008","unstructured":"Jiang YF, Jin QL, Li WY, Xu HN, Niu JQ. An analysis of CD4+CD25+CD127low\/\u2212 regulatory T cells and their immunological functions in patients with primary biliary cirrhosis. Chin J Hepatol (Chin) 2008;16:620\u2013621.","journal-title":"Chin J Hepatol (Chin)"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-0112-0962-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11655-0112-0962-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-0112-0962-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T12:28:35Z","timestamp":1593520115000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11655-0112-0962-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["962"],"URL":"https:\/\/doi.org\/10.1007\/s11655-0112-0962-9","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}